Forums » News and Announcements

Best Quality Peptide Octreotide CAS: 83150-76-9

    • 1209 posts
    September 19, 2019 5:26 AM EDT
    Best Quality Peptide Octreotide CAS: 83150-76-9





    Octreotide Acetate powder, Octreotide powder
    has also been used off-label for the treatment of severe, refractory
    diarrhea from other causes. It is used in toxicology for the treatment
    of prolonged recurrent hypoglycemia after sulfonylurea and possibly
    meglitinides overdose. It has also been used with varying degrees of
    success in infants with nesidioblastosis to help decrease insulin
    hypersecretion.

    Octreotide has been used experimentally to treat obesity, particularly
    obesity caused by lesions in the hunger and satiety centers of the
    hypothalamus, a region of the brain central to the regulation of food
    intake and energy expenditure. The circuit begins with an area of the
    hypothalamus, the arcuate nucleus, that has outputs to the lateral
    hypothalamus and ventromedial hypothalamus (VMH), the brain's feeding
    and satiety centers, respectively.The VMH is sometimes injured by
    ongoing treatment for acute lymphoblastic leukemia (ALL) or surgery or
    radiation to treat posterior cranial fossa tumors.



    APPLICATION

    1.Octreotide has also been used off-label for the treatment of severe,
    refractory diarrhea from other causes. It is used in toxicology for the
    treatment of prolonged recurrent hypoglycemia after sulfonylurea and
    possibly meglitinides overdose. It has also been used with varying
    degrees of success in infants with nesidioblastosis to help decrease
    insulin hypersecretion.



    2.Octreotide has been used experimentally to treat obesity, particularly
    obesity caused by lesions in the hunger and satiety centers of the
    hypothalamus, a region of the brain central to the regulation of food
    intake and energy expenditure.[4] The circuit begins with an area of the
    hypothalamus, the arcuate nucleus, that has outputs to the lateral
    hypothalamus (LH) and ventromedial hypothalamus (VMH), the brain's
    feeding and satiety centers, respectively.[5][6] The VMH is sometimes
    injured by ongoing treatment for acute lymphoblastic leukemia (ALL) or
    surgery or radiation to treat posterior cranial fossa tumors.